These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 1316229

  • 1. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C, Bhavani K, Chisari FV.
    Cancer Res; 1992 May 15; 52(10):2823-9. PubMed ID: 1316229
    [Abstract] [Full Text] [Related]

  • 2. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
    Kuo MT, Zhao JY, Teeter LD, Ikeguchi M, Chisari FV.
    Cell Growth Differ; 1992 Aug 15; 3(8):531-40. PubMed ID: 1356418
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
    Ghebranious N, Sell S.
    Hepatology; 1998 Feb 15; 27(2):383-91. PubMed ID: 9462635
    [Abstract] [Full Text] [Related]

  • 4. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
    Tabor E.
    Princess Takamatsu Symp; 1995 Feb 15; 25():151-61. PubMed ID: 8875620
    [Abstract] [Full Text] [Related]

  • 5. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F, Vangieri B, Cecere A, Gattoni A.
    Clin Ter; 2004 May 15; 155(5):187-99. PubMed ID: 15344567
    [Abstract] [Full Text] [Related]

  • 6. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX.
    Ai Zheng; 2005 Jun 15; 24(6):757-68. PubMed ID: 15946497
    [Abstract] [Full Text] [Related]

  • 7. Functional inactivation but not structural mutation of p53 causes liver cancer.
    Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G.
    Nat Genet; 1995 Jan 15; 9(1):41-7. PubMed ID: 7704023
    [Abstract] [Full Text] [Related]

  • 8. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.
    Oncogene; 2001 Jul 27; 20(33):4568-75. PubMed ID: 11494152
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
    Kasai Y, Takeda S, Takagi H.
    Semin Surg Oncol; 1996 Jul 27; 12(3):155-9. PubMed ID: 8727603
    [Abstract] [Full Text] [Related]

  • 10. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
    Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S.
    Cancer Res; 1994 Jan 01; 54(1):231-5. PubMed ID: 8261444
    [Abstract] [Full Text] [Related]

  • 11. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
    Pascale RM, Simile MM, Feo F.
    Anticancer Res; 1993 Jan 01; 13(5A):1341-56. PubMed ID: 8239505
    [Abstract] [Full Text] [Related]

  • 12. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
    Zhu MH, Ni CR, Zhu Z, Li FM, Zhang SM.
    Ai Zheng; 2003 Jul 01; 22(7):680-5. PubMed ID: 12866955
    [Abstract] [Full Text] [Related]

  • 13. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 14. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
    Henkler F, Waseem N, Golding MH, Alison MR, Koshy R.
    Cancer Res; 1995 Dec 15; 55(24):6084-91. PubMed ID: 8521397
    [Abstract] [Full Text] [Related]

  • 15. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice.
    Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C, Wang D, Sun Y, Hu G, Lang Z, Huang C, Yang X.
    Hepatology; 2004 Feb 15; 39(2):318-24. PubMed ID: 14767984
    [Abstract] [Full Text] [Related]

  • 16. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS.
    Cancer Res; 1994 Jan 01; 54(1):281-5. PubMed ID: 7903205
    [Abstract] [Full Text] [Related]

  • 17. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
    Kiran M, Chawla YK, Kaur J.
    Cancer Genet Cytogenet; 2009 Dec 01; 195(2):112-9. PubMed ID: 19963110
    [Abstract] [Full Text] [Related]

  • 18. [Transgenic mouse model for hepatocellular carcinoma in human hepatitis B virus infection].
    Koike K.
    Nihon Rinsho; 1993 Feb 01; 51(2):536-41. PubMed ID: 8385245
    [Abstract] [Full Text] [Related]

  • 19. [Transgenic mice and their use in cancer study].
    Yamamura K.
    Gan To Kagaku Ryoho; 1989 Apr 01; 16(4 Pt 1):733-9. PubMed ID: 2496665
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D.
    Mol Cancer Res; 2007 Nov 01; 5(11):1159-70. PubMed ID: 18025261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.